Related Experiment Video
Updated: Jan 16, 2026
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
Published on: November 10, 2013
Developing a novel Cu(II) complex: Crystal structure, cyclic voltammetry, biomolecular interactions, anticancer
Hagar E Badr1, Mohamed M Aboelnga2, Abdelaziz Elgamouz3
1Chemistry Department, Faculty of Science, Damietta University, New Damietta 34517, Egypt.
Abstract:
A new copper(II) Schiff base complex [Cu(L)2] derived from 2-hydroxybenzaldehyde-4-aminomethylbenzoate (HL) has been synthesized. The Characterization was performed by single crystal X-ray crystallography, FTIR, (1H,13C) NMR (for the ligand), Electrospray Ionization Mass Spectrometry (ESI-MS), UV-visible spectra, thermogravimetric analysis (TGA), cyclic voltammetry (CV) measurements, and DFT calculations. The analyses showed that the copper(II) complex has a distorted square planar geometry with two ligand molecules coordinated through the deprotonated phenolate oxygen and azomethine nitrogen (NO-donor). The stacking interaction of the ligand and the complex with calf thymus (ctDNA) and bovine serum albumin (BSA) was confirmed by UV-visible and fluorescence spectroscopy. The obtained data revealed that the Cu(II) complex is binding more strongly (1.77 × 105 M-1) to the ctDNA than the ligand (3.6 × 104 M-1) as an example. The interaction of the complex with ctDNA and BSA was also confirmed by cyclic voltammetry and an extended study for L-tyrosine, lysozyme, and glutathione. Molecular docking was also performed to obtain deeper structural insights into these interactions with BSA and DNA. Furthermore, in vitro cytotoxic activity against human normal lung cells (WI38), colorectal carcinoma (HCT116), and breast cancer (MDA-MB-231) was studied using cisplatin as a standard drug. The IC50 and selective index (SI) data showed that the Cu(II) complex is more active and selective toward both cancer cells compared to the free ligand, particularly in MDA-MB-231 cell lines, and flow cytometry analysis showed that the Cu(II) complex induces apoptosis in these cells. The treatment with the Cu(II) complex increases caspase3 and reduces PCNA expression. Moreover, it reduces metastasis in MDA-MB-231 cells after 48 h of treatment, probably due to its strong binding affinity to cancer cell DNA.
More Related Videos
11:38Quantifying the Binding Interactions Between CuII and Peptide Residues in the Presence and Absence of Chromophores
Published on: April 5, 2022
07:20Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
Related Concept Videos
02:58Crystal Field Theory - Octahedral Complexes
To explain the observed behavior of transition metal complexes (such as colors), a model involving electrostatic interactions between the electrons from the ligands and the electrons in the unhybridized d orbitals of the central metal atom has been developed. This electrostatic model is crystal field theory (CFT). It helps to understand, interpret, and predict the colors, magnetic behavior, and some structures of coordination compounds of transition metals.
CFT focuses on...
02:46Crystal Field Theory - Tetrahedral and Square Planar Complexes
Crystal field theory (CFT) is applicable to molecules in geometries other than octahedral. In octahedral complexes, the lobes of the dx2−y2 and dz2 orbitals point directly at the ligands. For tetrahedral complexes, the d orbitals remain in place, but with only four ligands located between the axes. None of the orbitals points directly at the tetrahedral ligands. However, the dx2−y2 and dz2 orbitals (along the Cartesian axes) overlap with the ligands less than the dxy,...